Analyst Price Target is $19.11
▲ +26.78% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for R1 RCM in the last 3 months. The average price target is $19.11, with a high forecast of $25.00 and a low forecast of $10.00. The average price target represents a 26.78% upside from the last price of $15.07.
Current Consensus is
The current consensus among 16 contributing investment analysts is to moderate buy stock in R1 RCM. This Moderate Buy consensus rating has held steady for over two years.
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. R1 RCM Inc. was founded in 2003 and is headquartered in Murray, Utah.